NCT05632419 Prognosis of Patients Who Presented With a State of Extreme Agitation.
| NCT ID | NCT05632419 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Emergence Delirium |
| Study Type | OBSERVATIONAL |
| Enrollment | 608 participants |
| Start Date | 2023-01-17 |
| Primary Completion | 2027-01-17 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 608 participants in total. It began in 2023-01-17 with a primary completion date of 2027-01-17.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main objective is to assess the 6-month prognosis of patients who presented with extreme agitation in the emergency room. The primary endpoint is the 6-month mortality of agitated patients.
Eligibility Criteria
Inclusion Criteria: * Agitated patient with the presence of three major criteria, namely, * restlessness * insensitivity to pain * tachypnea (fr\>20) and the presence of a minor criterion among * sweating * skin hyperthermia * non-compliance with law enforcement * tirelessness * unusual strength * inappropriate clothing, nudity Exclusion Criteria: * patient age \< 18 years * head trauma * pregnancy * detained * other obvious causes of pain leading to restlessness (renal colic, migraines, etc.)
Contact & Investigator
Frédéric Adnet, MD, PhD
PRINCIPAL INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Frequently Asked Questions
Who can join the NCT05632419 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Emergence Delirium. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05632419 currently recruiting?
Yes, NCT05632419 is actively recruiting participants. Contact the research team at frederic.adnet@avc.aphp.fr for enrollment information.
Where is the NCT05632419 trial being conducted?
This trial is being conducted at Bobigny, France.
Who is sponsoring the NCT05632419 clinical trial?
NCT05632419 is sponsored by Assistance Publique - Hôpitaux de Paris. The principal investigator is Frédéric Adnet, MD, PhD at Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 608 participants.